Key result
Modified De Vega's annuloplasty reduces functional TR to Grade 1 or less in ~88% of patients.
Why the study?
Does modified De Vega's annuloplasty improve tricuspid regurgitation and survival in patients with functional tricuspid regurgitation associated with left-sided valve disease?
Cohort (n=321)
No
Does modified De Vega's annuloplasty improve tricuspid regurgitation and survival in patients with functional tricuspid regurgitation associated with left-sided valve disease?
Modified De Vega's annuloplasty is a reliable procedure that effectively reduces the severity of functional tricuspid regurgitation and provides excellent long-term survival and freedom from reoperation.
Authors
No takes yet. Share an insight, caveat, or question.
Supports modified De Vega annuloplasty for functional TR with left-sided disease; leaves open confirmation versus alternatives in randomized trials.
Aoyagi et al. (1992) conducted a cohort in Functional tricuspid regurgitation (n=321). Modified De Vega's annuloplasty was evaluated on Reduction of tricuspid regurgitation severity to Grade 1 or less. Modified De Vega's annuloplasty reduced the severity of functional tricuspid regurgitation to Grade 1 or less in 88.4% of evaluated patients, with a 10-year actuarial survival rate of 88.2%.
Synapse has enriched one closely related paper. Consider it for comparative context: